Artelo Biosciences, Inc.
ARTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001621221
No open-market purchases or sales by Artelo Biosciences, Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $132.0K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Artelo Biosciences, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 17 | 22 | +5 |
| Shares | 1.99M | 1.90M | −86.4K (−4.4%) |
| Value | $1.57M | $984.0K | −$585.0K (−37.3%) |
New holders (8)
Institutions that held Artelo Biosciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Commonwealth Equity Services, LLC | 27,470 | $14.0K | 0.00% |
| Two Sigma Securities, LLC | 24,622 | $13.0K | 0.00% |
| Susquehanna International Group, LLP | 16,284 | $8.00K | 0.00% |
| Millennium Management LLC | 11,977 | $6.00K | 0.00% |
| State Street Corp | 10,400 | $5.00K | 0.00% |
| Creative Financial Designs Inc | 1,075 | $1.00K | 0.00% |
| Morgan Stanley | 2 | $0 | 0.00% |
| Global Wealth Management Investment Advisory, Inc. | 475 | $0 | 0.00% |
Sold out (3)
Institutions that held Artelo Biosciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Boothbay Fund Management, LLC | 122,895 | $97.0K |
| LVM Capital Management Ltd | 12,000 | $9.00K |
| Advisor Group Holdings, Inc. | 35 | $0 |